SCHEMBL5863928

SCHEMBL5863928

CCCC1CCCCN1CCCc1ccc(N(Cc2ccc(O)cc2Cl)S(=O)(=O)c2c(C)cc(C)cc2C)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
OPRK1 P41145 1/20 0.34
KMT2A Q03164 1/20 0.33
SPHK2 Q9NRA0 3/20 0.33
SPHK1 Q9NYA1 3/20 0.33
NMT1 P30419 1/20 0.32
NR1I2 O75469 1/20 0.32
STAT3 P40763 1/20 0.32
STAT1 P42224 1/20 0.32
STAT5B P51692 1/20 0.32
KEAP1 Q14145 3/20 0.32
GAA P10253 1/20 0.32
EPHX2 P34913 1/20 0.32
HTT P42858 1/20 0.32
OPRD1 P41143 1/20 0.31
HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864171 0.89 HRH3 (0.37)
SCHEMBL5863899 0.89 DRD2 (0.38) DRD2DRD3KMT2ASPHK2SPHK1
SCHEMBL5863904 0.89 DRD2 (0.38) DRD2DRD3KMT2ASPHK2SPHK1
SCHEMBL5863747 0.87 OPRK1 (0.39) POLBTSHRSMN1; SMN2OPRK1KMT2A
SCHEMBL5864175 0.85 KEAP1 (0.40) DRD2DRD3POLBTSHRSMN1; SMN2
SCHEMBL5863949 0.85 KEAP1 (0.40) DRD2DRD3POLBTSHRSMN1; SMN2
SCHEMBL5864051 0.84 ABL1 (0.40) NMT1HSP90AA1HSP90AB1
SCHEMBL5864868 0.82 SIGMAR1 (0.38) OPRK1NMT1GAAEPHX2HTT
SCHEMBL5864110 0.80 NMT1 (0.37) NMT1KEAP1NFE2L2
SCHEMBL5864216 0.79 SIGMAR1 (0.40) KMT2ANMT1KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053212-B2 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC. (US) 2006-05-30 US disclosed
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor GHSR, GPER1, SSTR1 DRD2 2672/4885DRD3 3048/4885POLB 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.